“The combination of RA and antiestrogenic compounds, such as tamoxifen , synergistically decreases the proliferation of breast cancer cells and an interplay between retinoid and estrogen signaling has begun to be unraveled, turning these combinations into an appealing strategy for breast cancer treatment.”